----
Current ValuationThe current P/E ratio is 24.61, above the reasonable range, cheaper than 4.99% of the time in the past 3 years, and the industry ranks 13/74, the industry Median --.
24.61xP/E
$250.81Stock price
$10.19Earnings per share
24.61xP/E
Stock price$250.81Earnings per share$10.19
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 21.04x
- Typical range
- 19.57x–22.16x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
08162432
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
CVSUSCVS Health | 23.15x | 393.80% | $113.20B |
LHUSLabcorp | 28.76x | 29.02% | $28.87B |
DGXUSQuest Diagnostics | 24.61x | 17.98% | $27.68B |
CHEUSChemed | 28.06x | 21.43% | $7.92B |
OPCHUSOption Care Health | 22.65x | 18.20% | $4.75B |
MDUSPediatrix Medical | 16.63x | 0.69% | $2.50B |
ADUSUSAddus Homecare | 22.30x | 18.27% | $2.35B |
AMNUSAMN Healthcare Services | 16.90x | 174.65% | $1.77B |
VMDUSViemed Healthcare | 24.80x | 11.71% | $359.55M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
